Global Children Long-Acting Growth Hormone market size is predicted to grow from US$ 10180 million in 2025 to US$ 14880 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031. Get Access Now!

Global Children Long-Acting Growth Hormone Market Growth Status and Outlook 2025-2031

The global Children Long-Acting Growth Hormone market size is predicted to grow from US$ 10180 million in 2025 to US$ 14880 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031. According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to Guide market players to produce safer and healthier domestic infant products. According to the National Bureau of Statistics, Chinas birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the childrens consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Childrens Industry shows that in 80% of families in China, childrens expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is 17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is 485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately. Infinity Market Research newest research report, the Children Long-Acting Growth Hormone Industry Forecast looks at past sales and reviews total world Children Long-Acting Growth Hormone sales in 2024, providing a comprehensive analysis by region and market sector of projected Children Long-Acting Growth Hormone sales for 2025 through 2031. With Children Long-Acting Growth Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Children Long-Acting Growth Hormone industry. This Insight Report provides a comprehensive analysis of the global Children Long-Acting Growth Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Children Long-Acting Growth Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Children Long-Acting Growth Hormone market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Children Long-Acting Growth Hormone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Children Long-Acting Growth Hormone. This report presents a comprehensive overview, market shares, and growth opportunities of Children Long-Acting Growth Hormone market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Powder &nbsp;&nbsp;&nbsp; Solvent Segmentation by Application: &nbsp;&nbsp;&nbsp; Growth Hormone Deficiency (GHD) &nbsp;&nbsp;&nbsp; Turner Syndrome &nbsp;&nbsp;&nbsp; Chronic Renal Insufficiency &nbsp;&nbsp;&nbsp; Prader Willi Syndrome &nbsp;&nbsp;&nbsp; Small for Gestational Age(SGA) &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Novo Nordisk &nbsp;&nbsp;&nbsp; Eli Lilly &nbsp;&nbsp;&nbsp; Merck Serono &nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche &nbsp;&nbsp;&nbsp; Ferring Pharmaceuticals &nbsp;&nbsp;&nbsp; Ipsen &nbsp;&nbsp;&nbsp; LG Life Sciences &nbsp;&nbsp;&nbsp; Sandoz International &nbsp;&nbsp;&nbsp; Anhui Anke Biotechnology Key Questions Addressed in this Report What is the 10-year outlook for the global Children Long-Acting Growth Hormone market? What factors are driving Children Long-Acting Growth Hormone market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Children Long-Acting Growth Hormone market opportunities vary by end market size? How does Children Long-Acting Growth Hormone break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Children Long-Acting Growth Hormone Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Children Long-Acting Growth Hormone by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Children Long-Acting Growth Hormone by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Children Long-Acting Growth Hormone Segment by Type &nbsp;2.2.1 Powder &nbsp;2.2.2 Solvent &nbsp;2.3 Children Long-Acting Growth Hormone Sales by Type &nbsp;2.3.1 Global Children Long-Acting Growth Hormone Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Children Long-Acting Growth Hormone Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Children Long-Acting Growth Hormone Sale Price by Type (2020-2025) &nbsp;2.4 Children Long-Acting Growth Hormone Segment by Application &nbsp;2.4.1 Growth Hormone Deficiency (GHD) &nbsp;2.4.2 Turner Syndrome &nbsp;2.4.3 Chronic Renal Insufficiency &nbsp;2.4.4 Prader Willi Syndrome &nbsp;2.4.5 Small for Gestational Age(SGA) &nbsp;2.4.6 Others &nbsp;2.5 Children Long-Acting Growth Hormone Sales by Application &nbsp;2.5.1 Global Children Long-Acting Growth Hormone Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Children Long-Acting Growth Hormone Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Children Long-Acting Growth Hormone Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Children Long-Acting Growth Hormone Breakdown Data by Company &nbsp;3.1.1 Global Children Long-Acting Growth Hormone Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Children Long-Acting Growth Hormone Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Children Long-Acting Growth Hormone Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Children Long-Acting Growth Hormone Revenue by Company (2020-2025) &nbsp;3.2.2 Global Children Long-Acting Growth Hormone Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Children Long-Acting Growth Hormone Sale Price by Company &nbsp;3.4 Key Manufacturers Children Long-Acting Growth Hormone Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Children Long-Acting Growth Hormone Product Location Distribution &nbsp;3.4.2 Players Children Long-Acting Growth Hormone Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Children Long-Acting Growth Hormone by Geographic Region &nbsp;4.1 World Historic Children Long-Acting Growth Hormone Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Children Long-Acting Growth Hormone Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Children Long-Acting Growth Hormone Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Children Long-Acting Growth Hormone Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Children Long-Acting Growth Hormone Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Children Long-Acting Growth Hormone Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Children Long-Acting Growth Hormone Sales Growth &nbsp;4.4 APAC Children Long-Acting Growth Hormone Sales Growth &nbsp;4.5 Europe Children Long-Acting Growth Hormone Sales Growth &nbsp;4.6 Middle East & Africa Children Long-Acting Growth Hormone Sales Growth 5 Americas &nbsp;5.1 Americas Children Long-Acting Growth Hormone Sales by Country &nbsp;5.1.1 Americas Children Long-Acting Growth Hormone Sales by Country (2020-2025) &nbsp;5.1.2 Americas Children Long-Acting Growth Hormone Revenue by Country (2020-2025) &nbsp;5.2 Americas Children Long-Acting Growth Hormone Sales by Type (2020-2025) &nbsp;5.3 Americas Children Long-Acting Growth Hormone Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Children Long-Acting Growth Hormone Sales by Region &nbsp;6.1.1 APAC Children Long-Acting Growth Hormone Sales by Region (2020-2025) &nbsp;6.1.2 APAC Children Long-Acting Growth Hormone Revenue by Region (2020-2025) &nbsp;6.2 APAC Children Long-Acting Growth Hormone Sales by Type (2020-2025) &nbsp;6.3 APAC Children Long-Acting Growth Hormone Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Children Long-Acting Growth Hormone by Country &nbsp;7.1.1 Europe Children Long-Acting Growth Hormone Sales by Country (2020-2025) &nbsp;7.1.2 Europe Children Long-Acting Growth Hormone Revenue by Country (2020-2025) &nbsp;7.2 Europe Children Long-Acting Growth Hormone Sales by Type (2020-2025) &nbsp;7.3 Europe Children Long-Acting Growth Hormone Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Children Long-Acting Growth Hormone by Country &nbsp;8.1.1 Middle East & Africa Children Long-Acting Growth Hormone Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Children Long-Acting Growth Hormone Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Children Long-Acting Growth Hormone Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Children Long-Acting Growth Hormone Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Children Long-Acting Growth Hormone &nbsp;10.3 Manufacturing Process Analysis of Children Long-Acting Growth Hormone &nbsp;10.4 Industry Chain Structure of Children Long-Acting Growth Hormone 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Children Long-Acting Growth Hormone Distributors &nbsp;11.3 Children Long-Acting Growth Hormone Customer 12 World Forecast Review for Children Long-Acting Growth Hormone by Geographic Region &nbsp;12.1 Global Children Long-Acting Growth Hormone Market Size Forecast by Region &nbsp;12.1.1 Global Children Long-Acting Growth Hormone Forecast by Region (2026-2031) &nbsp;12.1.2 Global Children Long-Acting Growth Hormone Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Children Long-Acting Growth Hormone Forecast by Type (2026-2031) &nbsp;12.7 Global Children Long-Acting Growth Hormone Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Pfizer &nbsp;13.1.1 Pfizer Company Information &nbsp;13.1.2 Pfizer Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.1.3 Pfizer Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Pfizer Main Business Overview &nbsp;13.1.5 Pfizer Latest Developments &nbsp;13.2 Novo Nordisk &nbsp;13.2.1 Novo Nordisk Company Information &nbsp;13.2.2 Novo Nordisk Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.2.3 Novo Nordisk Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Novo Nordisk Main Business Overview &nbsp;13.2.5 Novo Nordisk Latest Developments &nbsp;13.3 Eli Lilly &nbsp;13.3.1 Eli Lilly Company Information &nbsp;13.3.2 Eli Lilly Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.3.3 Eli Lilly Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Eli Lilly Main Business Overview &nbsp;13.3.5 Eli Lilly Latest Developments &nbsp;13.4 Merck Serono &nbsp;13.4.1 Merck Serono Company Information &nbsp;13.4.2 Merck Serono Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.4.3 Merck Serono Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Merck Serono Main Business Overview &nbsp;13.4.5 Merck Serono Latest Developments &nbsp;13.5 F. Hoffmann-La Roche &nbsp;13.5.1 F. Hoffmann-La Roche Company Information &nbsp;13.5.2 F. Hoffmann-La Roche Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.5.3 F. Hoffmann-La Roche Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 F. Hoffmann-La Roche Main Business Overview &nbsp;13.5.5 F. Hoffmann-La Roche Latest Developments &nbsp;13.6 Ferring Pharmaceuticals &nbsp;13.6.1 Ferring Pharmaceuticals Company Information &nbsp;13.6.2 Ferring Pharmaceuticals Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.6.3 Ferring Pharmaceuticals Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Ferring Pharmaceuticals Main Business Overview &nbsp;13.6.5 Ferring Pharmaceuticals Latest Developments &nbsp;13.7 Ipsen &nbsp;13.7.1 Ipsen Company Information &nbsp;13.7.2 Ipsen Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.7.3 Ipsen Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Ipsen Main Business Overview &nbsp;13.7.5 Ipsen Latest Developments &nbsp;13.8 LG Life Sciences &nbsp;13.8.1 LG Life Sciences Company Information &nbsp;13.8.2 LG Life Sciences Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.8.3 LG Life Sciences Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 LG Life Sciences Main Business Overview &nbsp;13.8.5 LG Life Sciences Latest Developments &nbsp;13.9 Sandoz International &nbsp;13.9.1 Sandoz International Company Information &nbsp;13.9.2 Sandoz International Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.9.3 Sandoz International Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Sandoz International Main Business Overview &nbsp;13.9.5 Sandoz International Latest Developments &nbsp;13.10 Anhui Anke Biotechnology &nbsp;13.10.1 Anhui Anke Biotechnology Company Information &nbsp;13.10.2 Anhui Anke Biotechnology Children Long-Acting Growth Hormone Product Portfolios and Specifications &nbsp;13.10.3 Anhui Anke Biotechnology Children Long-Acting Growth Hormone Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Anhui Anke Biotechnology Main Business Overview &nbsp;13.10.5 Anhui Anke Biotechnology Latest Developments 14 Research Findings and Conclusion

Report	Global Children Long-Acting Growth Hormone Market Growth 2025-2031
Selected License	Multi ID: LPI36482

Buyer Information

Order Summary